Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bataille

Showing results (241-250 of 322) with videos related to

Pageof 33
Sort By:
Blood|December 15, 1996
Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasoneD Puthier, R Bataille, S Barillé, et al.
Hematology and Cell Therapy|March 14, 1998
Analysis of platelet recovery after autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis productsS Hermouet, A E Niaussat, A Briec, et al.
Genes, Chromosomes & Cancer|September 1, 1999
Amplification of the 11q23 region in acute myeloid leukemiaH Avet-Loiseau, C Godon, J Y Li, et al.
British Journal of Haematology|February 1, 1996
G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myelomaB Mahé, N Milpied, S Hermouet, et al.
Cancer Research|June 15, 1991
No expansion of the pre-B and B-cell compartments in the bone marrow of patients with multiple myelomaC Duperray, R Bataille, J M Boiron, et al.
European Journal of Immunology|March 31, 2000
The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cellsC Pellat-Deceunynck, M P Mellerin, N Labarrière, et al.
Presse Medicale (Paris, France : 1983)|November 1, 1986
[Prolonged survival in multiple myeloma. Characteristics of presentation and response to treatment of 73 patients who survived 5 years or longer]J G Fuzibet, R Bataille, D Bagarry, et al.
Leukemia|August 30, 2002
Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myelomaP Moreau, R Misbahi, N Milpied, et al.
Blood|October 15, 1994
Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cellsC Pellat-Deceunynck, R Bataille, N Robillard, et al.
The New England Journal of Medicine|March 3, 1994
Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibodyJ T Beck, S M Hsu, J Wijdenes, et al.
Pageof 33

Showing results (241-250 of 322) with videos related to

Sort By:
Pageof 33
Blood|December 15, 1996
Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasoneD Puthier, R Bataille, S Barillé, et al.
Hematology and Cell Therapy|March 14, 1998
Analysis of platelet recovery after autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis productsS Hermouet, A E Niaussat, A Briec, et al.
Genes, Chromosomes & Cancer|September 1, 1999
Amplification of the 11q23 region in acute myeloid leukemiaH Avet-Loiseau, C Godon, J Y Li, et al.
British Journal of Haematology|February 1, 1996
G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myelomaB Mahé, N Milpied, S Hermouet, et al.
Cancer Research|June 15, 1991
No expansion of the pre-B and B-cell compartments in the bone marrow of patients with multiple myelomaC Duperray, R Bataille, J M Boiron, et al.
European Journal of Immunology|March 31, 2000
The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cellsC Pellat-Deceunynck, M P Mellerin, N Labarrière, et al.
Presse Medicale (Paris, France : 1983)|November 1, 1986
[Prolonged survival in multiple myeloma. Characteristics of presentation and response to treatment of 73 patients who survived 5 years or longer]J G Fuzibet, R Bataille, D Bagarry, et al.
Leukemia|August 30, 2002
Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myelomaP Moreau, R Misbahi, N Milpied, et al.
Blood|October 15, 1994
Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cellsC Pellat-Deceunynck, R Bataille, N Robillard, et al.
The New England Journal of Medicine|March 3, 1994
Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibodyJ T Beck, S M Hsu, J Wijdenes, et al.
Pageof 33